Allogene Therapeutics, Inc. Public Float
Allogene Therapeutics, Inc. (ALLO) had Public Float of $184.00 million as of 2025-06-30, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-12
- 2025-06-30: Entity Public Float $184.00M.
- 2024-06-28: Entity Public Float $354.00M.
- 2023-06-30: Entity Public Float $557.00M.
- 2022-06-30: Entity Public Float $1.01B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $184.00M 10-K · filed 2026-03-12 |
| 2024-06-28 | $354.00M 10-K · filed 2025-03-13 |
| 2023-06-30 | $557.00M 10-K · filed 2024-03-14 |
| 2022-06-30 | $1.01B 10-K/A · filed 2024-03-14 |
| 2021-06-30 | $2.25B 10-K · filed 2022-02-23 |
| 2020-06-30 | $3.51B 10-K · filed 2021-02-25 |
| 2019-06-28 | $1.60B 10-K · filed 2020-02-27 |
| 2018-06-30 | $0.00 10-K · filed 2019-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |